Location History:
- Wuppertal, DE (2004 - 2010)
- Melle, DE (2012 - 2014)
Company Filing History:
Years Active: 2004-2014
Title: Peter Ellinghaus: Innovator in Pharmaceutical Chemistry
Introduction
Peter Ellinghaus is a notable inventor based in Melle, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating hyper-proliferative disorders and diseases associated with angiogenesis. With a total of five patents to his name, Ellinghaus has established himself as a key figure in his area of expertise.
Latest Patents
Ellinghaus's latest patents include innovative compounds that have the potential to revolutionize treatment options. One of his notable inventions is the "Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis." This invention focuses on novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing these compounds, and their use in treating hyper-proliferative and/or angiogenesis disorders, either as a sole agent or in combination with other active ingredients or therapeutic measures. Another significant patent is "Substituted heterocyclylbenzylpyrazoles and use thereof." This application relates to novel substituted 1-[3-(heterocyclyl)benzyl]-1H-pyrazole derivatives, detailing processes for their preparation and their use in the treatment and prevention of diseases, particularly those arising from metabolic adaptation to hypoxic states.
Career Highlights
Throughout his career, Peter Ellinghaus has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Intellectual Property GmbH and Bayer Schering Pharma AG, where he has contributed to various research and development projects. His work has focused on creating effective treatments for complex medical conditions, showcasing his dedication to advancing healthcare solutions.
Collaborations
Ellinghaus has collaborated with several professionals in his field, including Michael Härter and Hartmut Beck. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical chemistry.
Conclusion
Peter Ellinghaus is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of hyper-proliferative disorders and diseases associated with angiogenesis. His contributions through patents and collaborations reflect his commitment to improving healthcare outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.